SCHEMBL2482022

SCHEMBL2482022

CN1CCC(Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3ccc4[nH]ccc4c3)cc2[N+](=O)[O-])C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 2/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1956893 1.00 BCL2 (0.94) BCL2
SCHEMBL1703407 0.97 BCL2 (1.00) BCL2
SCHEMBL30467959 0.97 BCL2 (1.00) BCL2
SCHEMBL1956205 0.94 BCL2 (0.87) BCL2
SCHEMBL1959124 0.94 BCL2 (0.90) BCL2
SCHEMBL1954919 0.94 BCL2 (0.92) BCL2
SCHEMBL1955278 0.93 BCL2 (0.91) BCL2
SCHEMBL1956083 0.93 BCL2 (0.91) BCL2
SCHEMBL1958050 0.93 BCL2 (0.91) BCL2
SCHEMBL2830750 0.93 BCL2 (0.89) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376480-A2 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES Abbott Laboratories (US) 2011-10-19 — — EP claimed
WO-2010065865-A2 BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-06-10 — — WO claimed
Send feedback